Lithostat

Product NDC
0178-0500
11-digit product format
001780500
Labeler code
0178
Product ID
0178-0500_47e7b4dd-b3b1-f6a0-e063-6294a90a1bca
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
acetohydroxamic acid
Dosage form
TABLET
Route
ORAL
Labeler
Mission Pharmacal Company
Application
NDA018749
Marketing category
NDA
Marketing start
1983-05-31
Substance
ACETOHYDROXAMIC ACID
Active strength
250 mg/1
Pharmacologic classes
Urease Inhibitor [EPC], Urease Inhibitors [MoA]
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 2 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source dateDatasetScopeProduct NDCPackage NDCCodeStatusReporting periodArchiveSnapshotSource SHA-256
2020-06-10 20:45 UTC · source 2020-06-10excluded productproduct0178-0500IInactivated by FDAexcluded / ndc_excluded.zip9bebd1f3094a…5416666fcb17…
2020-06-10 20:45 UTC · source 2020-06-10excluded packagepackage0178-05000178-0500-01IInactivated by FDAexcluded / ndc_excluded.zip9bebd1f3094a…5416666fcb17…

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N018749-001LITHOSTATACETOHYDROXAMIC ACID250MGTABLET / ORALRLD, RS1983-05-31

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08N018749-001LITHOSTAT250MGTABLET / ORALRLD, RS1983-05-3184e616aacf4f…
2026-08-18 06:07:402026-07N018749-001LITHOSTAT250MGTABLET / ORALRLD, RS1983-05-31caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N018749-001LITHOSTAT250MGTABLET / ORALRLD, RS1983-05-31011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N018749-001LITHOSTAT250MGTABLET / ORALRLD, RS1983-05-3131067a03dcf5…
2025-08-23 18:47 UTC2025-08N018749-001LITHOSTAT250MGTABLET / ORALRLD, RS1983-05-316a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N018749-001LITHOSTAT250MGTABLET / ORALRLD, RS1983-05-31fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N018749-001LITHOSTAT250MGTABLET / ORALRLD, RS1983-05-31b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N018749-001LITHOSTAT250MGTABLET / ORALRLD, RS1983-05-3103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N018749-001LITHOSTAT250MGTABLET / ORALRLD, RS1983-05-312680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N018749-001LITHOSTAT250MGTABLET / ORALRLD, RS1983-05-315bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N018749-001LITHOSTAT250MGTABLET / ORALRLD, RS1983-05-31d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N018749-001LITHOSTAT250MGTABLET / ORALRLD, RS1983-05-31d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N018749-001LITHOSTAT250MGTABLET / ORALRLD, RS1983-05-3179d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N018749-001LITHOSTAT250MGTABLET / ORALRLD, RS1983-05-31301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N018749-001LITHOSTAT250MGTABLET / ORALRLD, RS1983-05-311e350fbaab3a…
2024-05-31 18:47 UTC2024-05N018749-001LITHOSTAT250MGTABLET / ORALRLD, RS1983-05-318072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N018749-001LITHOSTAT250MGTABLET / ORALRLD, RS1983-05-315c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04N018749-001LITHOSTAT250MGTABLET / ORALRLD, RS1983-05-315d02ea3f76ae…
2022-04-04 05:41 UTC2022-04N018749-001LITHOSTAT250MGTABLET / ORALRLD, RS1983-05-314b0b4de00fa7…
2019-12-13 00:20 UTC2019-12N018749-001LITHOSTAT250MGTABLET / ORALRLD, RS1983-05-3174a2ff9319b5…
2022-03-09 01:35 UTC2022-03N018749-001LITHOSTAT250MGTABLET / ORALRLD, RS1983-05-31bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12N018749-001LITHOSTAT250MGTABLET / ORALRLD, RS1983-05-31782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05N018749-001LITHOSTAT250MGTABLET / ORALRLD, RS1983-05-3187673890dc5c…
2021-03-12 10:30 UTC2021-03N018749-001LITHOSTAT250MGTABLET / ORALRLD, RS1983-05-315aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12N018749-001LITHOSTAT250MGTABLET / ORALRLD, RS1983-05-318869cabd3fbd…
2020-11-12 02:37 UTC2020-11N018749-001LITHOSTAT250MGTABLET / ORALRLD, RS1983-05-31c0c555d07b60…
2019-12-14 00:12 UTC2019-12N018749-001LITHOSTAT250MGTABLET / ORALRLD, RS1983-05-313f01610625f2…
2019-09-15 20:21 UTC2019-09N018749-001LITHOSTAT250MGTABLET / ORALRLD, RS1983-05-31b00525d2431f…
2019-07-19 19:46 UTC2019-07N018749-001LITHOSTAT250MGTABLET / ORALRLD, RS1983-05-31ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03N018749-001LITHOSTAT250MGTABLET / ORALRLD, RS1983-05-316a51e52b5d6a…
2024-02-18 07:12 UTC2024-02N018749-001LITHOSTAT250MGTABLET / ORALRLD, RS1983-05-311c564ffb4f44…
2023-12-20 04:57 UTC2023-12N018749-001LITHOSTAT250MGTABLET / ORALRLD, RS1983-05-31ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11N018749-001LITHOSTAT250MGTABLET / ORALRLD, RS1983-05-31a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10N018749-001LITHOSTAT250MGTABLET / ORALRLD, RS1983-05-319b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07N018749-001LITHOSTAT250MGTABLET / ORALRLD, RS1983-05-31a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06N018749-001LITHOSTAT250MGTABLET / ORALRLD, RS1983-05-313f0d92c62455…
2023-05-13 08:27 UTC2023-05N018749-001LITHOSTAT250MGTABLET / ORALRLD, RS1983-05-31053a50430f4f…
2023-01-26 05:58 UTC2023-01N018749-001LITHOSTAT250MGTABLET / ORALRLD, RS1983-05-313bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11N018749-001LITHOSTAT250MGTABLET / ORALRLD, RS1983-05-313a93d1ddd44b…
2022-10-28 04:53 UTC2022-10N018749-001LITHOSTAT250MGTABLET / ORALRLD, RS1983-05-31f41ea6bd6efb…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product
Yes
Brand name base
Lithostat
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
ACETOHYDROXAMIC ACID250 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
4RZ82L2GY5Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
197308Internal RxNorm lookup
213557Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
6660b616-a82d-9109-19ce-2bdf9747aceaAvailable on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
69d53c56-a4c7-54ae-c338-8d2086506799Product name120140508

FDA-Initiated Inactive NDC Indexing#

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
0178-0500-01Lithostat100 in 1 BOTTLETABLET1007

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
0178-0500-01EA - Each0178-05006ad63b6f-30ec-4e43-b3f6-361cfbf8a8f512013-02-13

DailyMed Socrata Ingredients#

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
0178-0500LITHOSTAT (ACETOHYDROXAMIC ACID) TABLET [MISSION PHARMACAL COMPANY]6Current NDC, Legacy NDC, 1 package rows20240110_6660b616-a82d-9109-19ce-2bdf9747acea.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
LithostatACETOHYDROXAMIC ACIDMission Pharmacal Company6660b616-a82d-9109-19ce-2bdf9747acea2026-01-08Warnings, Adverse reactionsExact identifier
application applno (NDA): 018749
application number: NDA018749
ndc (product): 0178-0500

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
197308acetohydroxamic acid 250 MG Oral TabletPSN6660b616-a82d-9109-19ce-2bdf9747acea7
213557Lithostat 250 MG Oral TabletPSN6660b616-a82d-9109-19ce-2bdf9747acea7
213557acetohydroxamic acid 250 MG Oral Tablet [Lithostat]SBD6660b616-a82d-9109-19ce-2bdf9747acea7
197308acetohydroxamic acid 250 MG Oral TabletSCD6660b616-a82d-9109-19ce-2bdf9747acea7
213557Lithostat 250 MG Oral TabletSY6660b616-a82d-9109-19ce-2bdf9747acea7

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
0178-0500-0100178050001100 TABLET in 1 BOTTLE (0178-0500-01) 100 tablet1983-05-310000-00-00NoNoCurrent